首页 | 本学科首页   官方微博 | 高级检索  
检索        

脂肪干细胞局部注射改善淋巴水肿的实验研究
引用本文:周晨笑,苏万春,李娜,梁顺涛,张国英,马刚,李沛霖,崔磊.脂肪干细胞局部注射改善淋巴水肿的实验研究[J].首都医学院学报,2020,41(6):869-875.
作者姓名:周晨笑  苏万春  李娜  梁顺涛  张国英  马刚  李沛霖  崔磊
作者单位:首都医科大学附属北京世纪坛医院整形外科,北京100089;首都医科大学附属北京世纪坛医院淋巴外科,北京100089;首都医科大学附属北京世纪坛医院中心实验室,北京100089;首都医科大学附属北京世纪坛医院整形外科,北京100089;首都医科大学附属北京世纪坛医院中心实验室,北京100089
基金项目:国家自然科学基金(81471798), 首都医科大学附属北京世纪坛医院中心实验室建设经费(2019-JS04)。
摘    要:目的 研究脂肪干细胞 (adipose derived stem cells, ADSCs)体内减轻炎性反应治疗淋巴水肿的可行性及作用机制,为淋巴水肿疾病的干细胞治疗探索新的思路。方法 提取小鼠皮下脂肪干细胞,体外培养、扩张至3~5代。建立淋巴水肿鼠尾模型,手术阻断鼠尾深、浅淋巴回流,造模当天,于皮下注射ADSCs或磷酸盐缓冲液(phosphate buffered solution,PBS),ADSCs组共20只小鼠,PBS对照组共30只小鼠。术后3周,分别用HE染色、Whole mount-BODIPY染色、Masson染色、免疫荧光染色检测鼠尾皮下组织/脂肪厚度、纤维化程度、淋巴管形态,干预后8周,FITC-Dextran检测淋巴回流。结果 ADSCs组淋巴水肿缓解,鼠尾体积在术后4周内较对照组减小;皮下脂肪厚度降低约40%;皮下组织的纤维化缓解,Masson染色结果显示胶原纤维所占面积比例下降约20%;高倍镜视野下的淋巴管数量未发生变化,但是横截面积减小约60%;FITC-Dextran检测淋巴回流发现,ADSCs组荧光染料通过手术切口明显多于PBS对照组。结论 ADSCs局部注射后,可缓解淋巴水肿。

关 键 词:淋巴水肿  干细胞  脂肪干细胞
收稿时间:2020-08-20

Adipose derived stem cells ameliorate experimental lymphedema
Zhou Chenxiao,Su Wanchun,Li Na,Liang Shuntao,Zhang Guoying,Ma Gang,Li Peilin,Cui Lei.Adipose derived stem cells ameliorate experimental lymphedema[J].Journal of Capital University of Medical Sciences,2020,41(6):869-875.
Authors:Zhou Chenxiao  Su Wanchun  Li Na  Liang Shuntao  Zhang Guoying  Ma Gang  Li Peilin  Cui Lei
Institution:1. Department of Plastic Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100089, China; 2. Department of Lymph Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100089, China; 3. Department of Central Laboratory, Beijing Shijitan Hospital, Capital Medical University, Beijing 100089, China
Abstract:Objective To explore the feasibility of locally injected adipose derived stem cells (ADSCs) in treating lymphedema via reduction of CD4+T cells. Methods ADSCs isolated from subcutaneous adipose tissue of C57BL/6J mice were cultured in vitro to passage 3 to 5. Tail lymphedema was created on C57BL/6J mice by disconnecting both superficial and deep lymphatic vessels. Mice in total of 50 that received surgery were randomly assigned to two groups immediately after surgery. Animals in group 1 were injected subcutaneously with 15μL of PBS as control. Mice in group 2 were injected with 5×105 nADSCs suspended in 15 μL of PBS. At every week after ADSCs injection, tail volumes of mouse tails were calculated. Tails were harvested at 3 weeks after injection. Subcutaneous adipose thickness, degree of fibrosis, lymphatic morphology and lymphatic reflux, were detected by Whole mount-BODIPY staining, Masson trichrome staining, immunofluorescence, and FITC-Dextran respectively. Results Transfer of ADSCs demonstrated an amelioration of lymphedema, which corresponded to a decrease in tail volume and nearly 40% decrease in adipose tissue thickness, as compared with controls. Using Masson trichrome staining, we found a 20% reduced collagen deposition after ADSCs transfer. Furthermore, the dramatic expansive lymphatic vessels were reduced by about 60% in area, while the total numbers were not changed. Transport function of lymphatic vessels was improved as evidenced by an increase in the amount of dye passing through the surgical incision within a limited time. Conclusion Local application of ADSCs alleviates lymphedema.
Keywords:lymphedema  stem cells  adipose derived stem cells  
本文献已被 万方数据 等数据库收录!
点击此处可从《首都医学院学报》浏览原始摘要信息
点击此处可从《首都医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号